Eastman Chemical (EMN) Tops Q2 EPS by 4c; Offers second half guidance

Eastman Chemical (NYSE: EMN) reported Q2 EPS of $1.99, $0.04 better than the analyst estimate of $1.95. Revenue for the quarter came in at $2.32 billion versus the consensus estimate of $2.59 billion.

GUIDANCE

The company expects second half adjusted earnings per share (EPS) to be somewhat below first half and for 2023 EPS to be between $6.50 and $7.00. In addition, we continue to expect to generate $1.4 billion of operating cash flow in 2023.”

For earnings history and earnings-related data on Eastman Chemical (EMN) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• MapLight Therapeutics, Inc. (MPLT) Misses Q2 EPS by 33c
• Lument Finance Trust (LFT) Misses Q2 EPS by 17c